In addition to our core pharmaceutical, nutrition and vaccine trial services, EB Medical Research conducts diagnostic studies and provides custom research support to sponsors and fellow research sites whose needs fall outside a standard trial design.
Our Almere site is equipped for the operational demands of medical research:
Cancer Biomarker study
An ongoing outcomes study evaluating a triple GIP/GLP-1/glucagon receptor agonist in adults with overweight or obesity and cardiovascular or renal comorbidity. The study is now in year 2 of an expected 5-year duration.
Infant Growth Study
For a global nutrition company, EB Medical Research conducted a study in babies aged 0–2 years, measuring length and weight and capturing photos and video to support the development of an app for accurately tracking growth. The study ran from 16 May 2025 to 5 February 2026, with 26 participants
When a Phase 1 clinical unit’s own site was unavailable during an 18-month renovation (late 2020 – April 2022), EB Medical Research took over all screening for their recruited candidates, 1,800 in total. Dedicated physicians and research assistants were hired specifically for this purpose.
EBMR has also recruited participants on behalf of other CROs and research sites.
If you are looking for a reliable site to discuss your research question, we are happy to explore the possibilities.
We respond within 16 business hours.